MA42910A - Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène - Google Patents

Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène

Info

Publication number
MA42910A
MA42910A MA42910A MA42910A MA42910A MA 42910 A MA42910 A MA 42910A MA 42910 A MA42910 A MA 42910A MA 42910 A MA42910 A MA 42910A MA 42910 A MA42910 A MA 42910A
Authority
MA
Morocco
Prior art keywords
hydrogen peroxide
compositions
phase
antimicrobial compositions
peroxide releasing
Prior art date
Application number
MA42910A
Other languages
English (en)
Inventor
John Reginald Barrett
James Brennan
Sophie Constance Cox
Liam Michael Grover
Thomas Jon Hall
Thomas Patton
Rami Salib
Ian Staples
Original Assignee
Matoke Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Priority claimed from GBGB1513045.3A external-priority patent/GB201513045D0/en
Publication of MA42910A publication Critical patent/MA42910A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Des compositions pour générer une activité antimicrobienne sont décrites. Les compositions comprennent: une première phase; une deuxième phase; une enzyme capable de convertir un substrat pour libérer du peroxyde d'hydrogène; et une substance qui comprend un substrat pour l'enzyme, la première phase et la seconde phase étant non miscibles. Les compositions peuvent être formulées sous forme de colloïdes, de suspensions ou d'émulsions, en particulier sous forme de crèmes ou de sprays. Des procédés de fabrication des compositions sont décrits, ainsi que leur utilisation pour le traitement d'infections antimicrobiennes.
MA42910A 2015-07-23 Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène MA42910A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1513045.3A GB201513045D0 (en) 2015-07-23 2015-07-23 Antimicrobial compositions and formulations
GB201606249 2016-04-12

Publications (1)

Publication Number Publication Date
MA42910A true MA42910A (fr) 2018-05-30

Family

ID=56555490

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42910A MA42910A (fr) 2015-07-23 Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène

Country Status (16)

Country Link
US (1) US20180318399A1 (fr)
EP (1) EP3324998A1 (fr)
JP (1) JP2018527320A (fr)
KR (1) KR20180051501A (fr)
CN (1) CN107847566A (fr)
AU (1) AU2016296150A1 (fr)
BR (1) BR112018001279A2 (fr)
CA (1) CA2990326A1 (fr)
CO (1) CO2018001628A2 (fr)
GB (1) GB2556567A (fr)
HK (1) HK1256251A1 (fr)
MA (1) MA42910A (fr)
MX (1) MX2018001002A (fr)
PH (1) PH12018500374A1 (fr)
RU (1) RU2018105622A (fr)
WO (1) WO2017013448A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016025331A2 (pt) 2014-04-30 2017-08-15 Matoke Holdings Ltd composições antimicrobianas
WO2018065789A1 (fr) * 2016-10-06 2018-04-12 Matoke Holdings Limited Compositions antimicrobiennes
WO2018091890A1 (fr) * 2016-11-15 2018-05-24 Matoke Holdings Limited Compositions et formulations antimicrobiennes
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
WO2019077336A1 (fr) * 2017-10-16 2019-04-25 Matoke Holdings Limited Double distributeur contenant de l'eau et une composition antimicrobienne
CN107668320A (zh) * 2017-11-03 2018-02-09 杭州市农业科学研究院 以蜂蜜为原料的饲料添加剂及其制备方法
WO2020022989A2 (fr) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Compositions topiques pour soins de peau de bébé
CN110734563B (zh) * 2018-07-20 2022-05-17 南京理工大学 细菌纤维素/鸸鹋油复合膜及其制备方法
EP3946481A2 (fr) 2019-03-27 2022-02-09 Matoke Holdings Limited Compositions antimicrobiennes
CN111631271A (zh) * 2020-05-22 2020-09-08 南昌大学 一种稳定w/o/w型多重乳液的制备方法
WO2023227599A1 (fr) * 2022-05-23 2023-11-30 Atlantic Technological University Composition de revêtement antimicrobienne

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5980875A (en) * 1996-04-12 1999-11-09 Mousa; Mahmoud A. Honey preparations
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
FR2769504B1 (fr) * 1997-10-13 2000-03-10 Oreal Utilisation du miel en tant qu'agent diminuant l'adhesion des micro-organismes
NL1017333C2 (nl) * 2001-02-12 2002-08-13 Gent Natural Products Van Cosmetisch resp. farmaceutisch preparaat.
AU2003234758B2 (en) * 2002-08-13 2009-04-02 Derma Sciences, Inc. Composition
BE1017155A3 (nl) * 2006-06-01 2008-03-04 Sanomedical Bvba Wondverzorgingsproduct.
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
DE102008034944B4 (de) * 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion
JP5750404B2 (ja) * 2012-06-14 2015-07-22 株式会社山田蜂蜜研究所 抗菌剤及び化粧料

Also Published As

Publication number Publication date
EP3324998A1 (fr) 2018-05-30
GB201801667D0 (en) 2018-03-21
RU2018105622A (ru) 2019-08-27
HK1256251A1 (zh) 2019-09-20
CO2018001628A2 (es) 2018-11-22
MX2018001002A (es) 2018-09-28
CN107847566A (zh) 2018-03-27
KR20180051501A (ko) 2018-05-16
AU2016296150A1 (en) 2018-03-01
PH12018500374A1 (en) 2018-08-20
BR112018001279A2 (pt) 2018-09-11
WO2017013448A1 (fr) 2017-01-26
GB2556567A (en) 2018-05-30
RU2018105622A3 (fr) 2020-02-21
JP2018527320A (ja) 2018-09-20
CA2990326A1 (fr) 2017-01-26
US20180318399A1 (en) 2018-11-08

Similar Documents

Publication Publication Date Title
PH12018500374A1 (en) Antimicrobial compositions and formulations releasing hydrogen peroxide
MA50949B1 (fr) Anticorps anti-ctla-4 et leurs procédés d'utilisation
MX2017013535A (es) Metodos y composiciones de limpieza personal concentradas.
EP4233843A3 (fr) Compositions d'anticorps
MX2023000289A (es) Moleculas que tienen utilidad plaguicida, e intermediarios, composiciones, y procesos, relacionados a las mismas.
MA34909B1 (fr) Triterpénoïdes modifi2s en c-17 et c-3 presentant une activité inhibitrice de la maturation du vih
MX2017012646A (es) Moleculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos, relacionados con ellas.
TN2014000195A1 (fr) 2-thiopyrimidinones
MX2017013533A (es) Composiciones de limpieza personal concentradas.
MX2018008846A (es) Moléculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos relacionados con ellas.
MA33208B1 (fr) Anticorps anti-fgfr3 et procédés d'utilisation de ceux-ci
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
MA50406B1 (fr) Inhibiteurs pyrazole de magl
MX2009013810A (es) Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos.
MX2018008845A (es) Moléculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos, relacionados con ellas.
MX2017006136A (es) Moleculas que tienen utilidad plaguicida e intermediarios, composiciones y procedimientos relacionados con las mismas.
MA40875A (fr) 2,4-diamino-quinoléine substituée servant de nouveaux agents anticancéreux
MA46548A (fr) Fsh pour le traitement de l'infertilité
MX2016017089A (es) Moleculas que tienen cierta utilidad plaguicida e intermediarios, composiciones y procedimientos relacionados con las mismas.
MA33693B1 (fr) Dérivés de pyrazole qui modulent la stéroyl-coa désaturase
MX2019011545A (es) Composiciones celulares y de andamio inyectables.
EP4406607A3 (fr) Anticorps pour radionuclides chelates
NZ739853A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
WO2017132019A8 (fr) Molécules présentant une utilité en tant que pesticides, et intermédiaires, compositions et procédés associés
MX2020010572A (es) Composiciones cosmeticas.